Lyra Therapeutics (LYRA) Current Leases (2019 - 2025)

Quarterly Current Leases rose 16.91% to $4.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.8 million through Dec 2025, up 16.91% year-over-year, with the annual reading at $4.8 million for FY2025, 16.91% up from the prior year.

Lyra Therapeutics' Current Leases history spans 7 years, with the latest figure at $4.8 million for Q4 2025.

  • Current Leases came in at $4.8 million for Q4 2025, up from $4.7 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $5.4 million in Q4 2023 to a low of $654000.0 in Q3 2022.
  • The 5-year median for Current Leases is $1.8 million (2023), against an average of $2.7 million.
  • Year-over-year, Current Leases plummeted 37.83% in 2022 and then surged 250.81% in 2023.
  • Lyra Therapeutics' Current Leases stood at $1.1 million in 2021, then soared by 44.23% to $1.5 million in 2022, then soared by 250.81% to $5.4 million in 2023, then dropped by 24.16% to $4.1 million in 2024, then increased by 16.91% to $4.8 million in 2025.
  • Per Business Quant, the three most recent readings for LYRA's Current Leases are $4.8 million (Q4 2025), $4.7 million (Q3 2025), and $4.6 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 83,991.00
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 7.40 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 720.00 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 45.66 Mn
10 Lyra Therapeutics - - - 4.82 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 4.82 Mn
Sep 30, 2025 4.68 Mn
Jun 30, 2025 4.55 Mn
Mar 31, 2025 4.24 Mn
Dec 31, 2024 4.12 Mn
Sep 30, 2024 4.00 Mn
Jun 30, 2024 4.27 Mn
Mar 31, 2024 4.50 Mn
Dec 31, 2023 5.43 Mn
Sep 30, 2023 1.40 Mn
Jun 30, 2023 1.69 Mn
Mar 31, 2023 1.90 Mn
Dec 31, 2022 1.55 Mn
Sep 30, 2022 654,000.00
Jun 30, 2022 926,000.00
Mar 31, 2022 1.10 Mn
Dec 31, 2021 1.07 Mn
Sep 30, 2021 1.05 Mn
Jun 30, 2021 1.03 Mn
Mar 31, 2021 1.01 Mn
Dec 31, 2020 985,000.00
Sep 30, 2020 964,000.00
Jun 30, 2020 943,000.00
Mar 31, 2020 919,000.00
Dec 31, 2019 899,000.00